BioXcel Therapeutics, Inc. (BTAI)
NASDAQ · Healthcare
BioXcel Therapeutics, Inc. Net Income 2022–2025
BioXcel Therapeutics, Inc. annual/quarterly net income history and growth rate from 2022 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- BioXcel Therapeutics, Inc. net income for the quarter ending March 31, 2026 was -12.7 M, a 74.95% increase year-over-year.
- BioXcel Therapeutics, Inc. net income for the twelve months ending March 31, 2026 was -70.0 M, a 29.41% decrease year-over-year.
- BioXcel Therapeutics, Inc. annual net income for 2025 was -69.9 M, a 17.28% increase from 2024.
- BioXcel Therapeutics, Inc. annual net income for 2024 was -59.6 M, a 66.71% decrease from 2023.
- BioXcel Therapeutics, Inc. annual net income for 2023 was -179.1 M, a 8.02% increase from 2022.
- BioXcel Therapeutics, Inc. annual net income for 2022 was -165.8 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
BioXcel Therapeutics, Inc. Net Income — FAQ
BioXcel Therapeutics, Inc. (BTAI) net income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is BioXcel Therapeutics, Inc.'s net income?
BioXcel Therapeutics, Inc. (BTAI) reported net income of -$70M for fiscal 2025.
Where can I see BTAI's net income history?
The chart and table above show BioXcel Therapeutics, Inc.'s net income by year and by quarter, including the growth rate.